Ftse Mib
34.326,90
0,51%
DAX
18.686,60
1,07%
S&P 500
5.208,35
0,40%
NASDAQ
16.346,19
0,27%
Bitcoin
61.961,32
1,26%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Singular Genomics Systems Inc (OMIC) Singular Genomics Systems Inc (OMIC) Notizie

Singular Genomics Systems Inc

OMIC
0,4401
0,0021 (0,48%)
Ultimo aggiornamento: 18:55:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202422:05GLOBESingular Genomics to Report First Quarter 2024 Financial..
18/3/202421:05GLOBESingular Genomics Reports Recent Highlights and Fourth..
04/3/202422:05GLOBESingular Genomics to Report Fourth Quarter and Full Year..
14/2/202422:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202416:55GLOBESingular Genomics Showcases New G4X™ Spatial Sequencer at..
05/2/202416:54GLOBESingular Genomics Unveils G4X™ Spatial Sequencer,..
19/1/202422:29EDGAR2Form 8-K - Current report
08/1/202412:01EDGAR2Form 8-K - Current report
07/1/202423:00GLOBESingular Genomics Reports Instrument Shipments and..
18/12/202323:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202322:01GLOBESingular Genomics Reports Recent Highlights and Third..
09/11/202323:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/10/202322:22GLOBESingular Genomics to Report Third Quarter 2023 Financial..
16/9/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:36EDGAR2Form 8-K - Current report
08/9/202314:00GLOBESingular Genomics to Present at the Gilmartin Group Emerging..
17/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:04EDGAR2Form 8-K - Current report
09/8/202322:01GLOBESingular Genomics Reports Recent Highlights and Second..
08/8/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/8/202322:10EDGAR2Form 8-K - Current report
08/8/202322:05GLOBESingular Genomics Appoints Genomics Veteran Marcia..
02/8/202322:05GLOBESingular Genomics Announces Participation in the UBS..
26/7/202322:05GLOBESingular Genomics to Report Second Quarter 2023 Financial..
20/7/202322:30EDGAR2Form 8-K - Current report
01/6/202322:05GLOBESingular Genomics to Present at the Goldman Sachs Global..
Apertura: 0,4391 Min: 0,436949 Max: 0,455
Chiusura: 0,438

La tua Cronologia

NASDAQ
OMIC
Singular Genomics Systems
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network